natgillin/translations-raw huggingface dataset:
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), as referred to in Council Implementing Decision (EU) 2017/2170.
N-fenil-N-[1-(2-feniletil)piperidin-4-il]furan-2-karboksamid (furanilfentanil), kako je naveden u Provedbenoj odluci Vijeća (EU) 2017/2170.
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), as referred to in Council Implementing Decision (EU) 2018/747.
N-(1-amino-3,3-dimetil-1-oksobutan-2-il)-1-(cikloheksilmetil)-1H-indazol-3-karboksamid (ADB-CHMINACA), kako je naveden u Provedbenoj odluci Vijeća (EU) 2018/747;
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), as referred to in Council Implementing Decision (EU) 2018/748.
1-(4-cijanobutil)-N-(2-fenilpropan-2-il)-1H-indazol-3-karboksamid (CUMYL-4CN-BINACA), kako je naveden u Provedbenoj odluci Vijeća (EU) 2018/748;
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), as referred to in Council Implementing Decision (EU) 2018/1463.
N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamid (ciklopropil-fentanil) i 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamid (metoksiacetil-fentanil), kako su navedeni u Provedbenoj odluci Vijeća (EU) 2018/1463.
OJ L 305, 21.11.2017, p. 12.
SL L 305, 21.11.2017., str. 12.
Council Implementing Decision (EU) 2017/2170 of 15 November 2017 on subjecting N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures (OJ L 306, 22.11.2017, p. 19).
Provedbena odluka Vijeća (EU) 2017/2170 od 15. studenoga 2017. o podvrgavanju tvari N-fenil-N-[1-(2-feniletil)piperidin-4-il]furan-2-karboksamida (furanilfentanila) kontrolnim mjerama (SL L 306, 22.11.2017., str. 19.).
Council Implementing Decision (EU) 2018/747 of 14 May 2018 on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures (OJ L 125, 22.5.2018, p. 8).
Provedbena odluka Vijeća (EU) 2018/747 od 14. svibnja 2018. o podvrgavanju nove psihoaktivne tvari N-(1-amino-3,3-dimetil-1-oksobutan-2-il)-1-(cikloheksilmetil)-1H-indazol-3-karboksamida (ADB-CHMINACA) kontrolnim mjerama (SL L 125, 22.5.2018., str. 8.).
Council Implementing Decision (EU) 2018/748 of 14 May 2018 on subjecting the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures (OJ L 125, 22.5.2018, p. 10).
Provedbena odluka Vijeća (EU) 2018/748 od 14. svibnja 2018. o podvrgavanju nove psihoaktivne tvari 1-(4-cijanobutil)-N-(2-fenilpropan-2-il)-1H-indazol-3-karboksamida (CUMYL-4CN-BINACA) kontrolnim mjerama (SL L 125, 22.5.2018., str. 10.).
Council Implementing Decision (EU) 2018/1463 of 28 September 2018 on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures (OJ L 245, 1.10.2018, p. 9).
Provedbena odluka Vijeća (EU) 2018/1463 od 28. rujna 2018. o podvrgavanju novih psihoaktivnih tvari N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamida (ciklopropil-fentanil) i 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamida (metoksiacetil-fentanil) kontrolnim mjerama (SL L 245, 1.10.2018., str. 9.).
Council Implementing Decision (EU) 2018/1463 of 28 September 2018 on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures (OJ L 245, 1.10.2018, p. 9).’.
Provedbena odluka Vijeća (EU) 2018/1463 od 28. rujna 2018. o podvrgavanju novih psihoaktivnih tvari N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamida (ciklopropil-fentanil) i 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamida (metoksiacetil-fentanil) kontrolnim mjerama (SL L 245, 1.10.2018., str. 9.).”
Directive (EU) 2017/2103 repealed Decision 2005/387/JHA with effect from 23 November 2018.
Odluka 2005/387/PUP stavljena je izvan snage Direktivom (EU) 2017/2103, s učinkom od 23. studenoga 2018.
From the adoption of Directive (EU) 2017/2103 until 23 November 2018, five new psychoactive substances were subjected to control measures and criminal penalties under Decision 2005/387/JHA.
Od donošenja Direktive (EU) 2017/2103 do 23. studenoga 2018. pet novih psihoaktivnih tvari podvrgnuto je kontrolnim mjerama i kaznenim sankcijama u skladu s Odlukom 2005/387/PUP.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 7 September 2019 at the latest.
Države članice donose zakone i druge propise potrebne za usklađivanje s ovom Direktivom najkasnije do 7. rujna 2019.
However, they shall bring into force the laws, regulations and administrative provisions necessary to comply with point 16 of the Annex to Framework Decision 2004/757/JHA referred to in Article 1 of this Directive by 29 September 2019.
Međutim, zakone i druge propise potrebne za usklađivanje s točkom 16. Priloga Okvirnoj odluci 2004/757/PUP iz članka 1. ove Direktive donose do 29. rujna 2019.
Regulation (EU) 2019/2 of the European Parliament and of the Council
Uredba (EU) 2019/2 Europskog parlamenta i Vijeća
amending Regulation (EC) No 1008/2008 on common rules for the operation of air services in the Community
o izmjeni Uredbe (EZ) br. 1008/2008 o zajedničkim pravilima za obavljanje zračnog prijevoza u Zajednici
Regulation (EC) No 1008/2008 of the European Parliament and of the Council includes provisions allowing lease agreements for aircraft registered in third countries, in particular wet lease agreements.
Uredba (EZ) br. 1008/2008 Europskog parlamenta i Vijeća sadržava odredbe kojima se dopuštaju ugovori o zakupu zrakoplova registriranih u trećim zemljama, posebno ugovori o zakupu zrakoplova s posadom.
Those agreements are permitted in exceptional circumstances, such as in the case of a lack of adequate aircraft in the Union market.
Ti su ugovori dozvoljeni u izvanrednim okolnostima, kao što je nedostatak odgovarajućih zrakoplova na tržištu Unije.
They should be strictly limited in time and should fulfil safety standards equivalent to the safety rules provided for in Union and national law.
Trebalo bi ih strogo vremenski ograničiti i oni bi trebali zadovoljavati sigurnosne standarde jednakovrijedne sigurnosnim pravilima predviđenima u pravu Unije i nacionalnom pravu.
The ATA provides for an open wet-lease regime between its parties.
SZP-om se predviđa otvoren režim zakupa zrakoplova s posadom između ugovornih stranaka SZP-a.
The relevant provisions that are included under Article 10 of the ATA permit wet lease agreements for international air transport, provided that all parties to such agreements have the appropriate authority and meet the conditions prescribed under the laws and regulations normally applied by the parties to the ATA.
Relevantnim odredbama iz članka 10. SZP-a dozvoljavaju se ugovori o zakupu zrakoplova s posadom za međunarodni zračni prijevoz pod uvjetom da sve stranke takvih ugovora imaju odgovarajuće odobrenje i ispunjavaju uvjete propisane zakonima i drugim propisima koje ugovorne stranke SZP-a uobičajeno primjenjuju.
Relevant developments and past discussions of the Joint Committee established under the ATA have shown that parties to the ATA would benefit from a dedicated wet lease agreement which would provide precision to the relevant provisions of the ATA.
Odgovarajući razvoj i dosadašnje rasprave Zajedničkog odbora uspostavljenog na temelju SZP-a pokazali su da bi ugovorne stranke SZP-a imale koristi od posebnog ugovora o zakupu zrakoplova s posadom kojim bi se dodatno precizirale odgovarajuće odredbe SZP-a.
Since such a wet lease agreement would involve the relaxation of the existing time limits, it would have a ripple effect on Regulation (EC) No 1008/2008, in which time limits are provided for in cases where Union carriers wet lease from third-country carriers.
Budući da bi takav ugovor o zakupu zrakoplova s posadom uključivao ublažavanje postojećih vremenskih ograničenja, on bi utjecao na Uredbu (EZ) 1008/2008 u kojoj su vremenska ograničenja predviđena za slučajeve kada prijevoznici iz Unije zakupljuju zrakoplov s posadom od prijevoznika iz trećih zemalja.
Regulation (EC) No 1008/2008 therefore needs to be amended to allow for the relaxation of time limits on wet-leasing to be agreed in international agreements concluded by the Union with third countries.
Uredbu (EZ) br. 1008/2008 potrebno je stoga izmijeniti kako bi se omogućilo ublaživanje vremenskih ograničenja za zakup zrakoplova s posadom koji se ugovara u međunarodnim sporazumima koje Unija sklapa s trećim zemljama.
Taking into account the fact that the Commission is currently reviewing Regulation (EC) No 1008/2008, including its provisions on wet-leasing and their possible impact on employees and consumers, and that the Commission's review could lead to a general revision of Regulation (EC) No 1008/2008, this Regulation is limited to aligning Regulation (EC) No 1008/2008 with the relevant international obligations.
Uzimajući u obzir činjenicu da Komisija trenutačno preispituje Uredbu (EZ) br. 1008/2008, uključujući njezine odredbe o zakupu zrakoplova s posadom i njihov mogući utjecaj na zaposlenike i potrošače, te da bi preispitivanje koje provodi Komisija moglo dovesti do opće revizije Uredbe (EZ) br. 1008/2008, ova Uredba ograničena je na usklađivanje Uredbe (EZ) br. 1008/2008 s relevantnim međunarodnim obvezama.
The international agreement on wet-leasing should include reciprocal rights and obligations for both parties and should be based on an existing Air Transport Agreement.
Međunarodnim sporazumom o zakupu zrakoplova s posadom trebalo bi obuhvatiti uzajamna prava i obveze obiju ugovornih stranaka te bi se on trebao temeljiti na postojećem Sporazumu o zračnom prijevozu.
Regulation (EC) No 1008/2008 should therefore be amended accordingly,
Uredbu (EZ) br. 1008/2008 trebalo bi stoga na odgovarajući način izmijeniti,
In point (b) of Article 13(3) of Regulation (EC) No 1008/2008, the introductory phrase is replaced by the following:
U članku 13. stavku 3. točki (b) Uredbe (EZ) br. 1008/2008 uvodna rečenica zamjenjuje se sljedećim:
‘unless otherwise provided for in an international agreement on wet-leasing signed by the Union which is based on an Air Transport Agreement to which the Union is a party and which was signed before 1 January 2008, one of the following conditions is fulfilled:’.
„osim ako je drugačije određeno u međunarodnom sporazumu o zakupu zrakoplova s posadom koji je potpisala Unija i koji se temelji na sporazumu o zračnom prijevozu čija je Unija stranka i koji je potpisan prije 1. siječnja 2008., ako je ispunjen jedan od sljedećih uvjeta:”.
OJ C 345, 13.10.2017, p. 126.
SL C 345, 13.10.2017., str. 126.
Position of the European Parliament of 29 November 2018 (not yet published in the Official Journal) and decision of the Council of 6 December 2018.
Stajalište Europskog parlamenta od 29. studenoga 2018. (još nije objavljeno u Službenom listu) i odluka Vijeća od 6. prosinca 2018.
OJ L 134, 25.5.2007, p. 4.
SL L 134, 25.5.2007., str. 4.
The Air Transport Agreement between the European Community and its Member States, on the one hand, and the United States of America, on the other hand (ATA) was signed on 25 April 2007 and subsequently amended by a Protocol of 24 June 2010.
Sporazum o zračnom prijevozu između Europske zajednice i njezinih država članica, s jedna strane, i Sjedinjenih Američkih Država, s druge strane (SZP) potpisan je 25. travnja 2007. te je kasnije izmijenjen Protokolom od 24. lipnja 2010.
The ATA reflects its parties' commitment to the shared goal of continuing to remove market access barriers in order to maximise benefits for consumers, airlines, labour and communities on both sides of the Atlantic.
SZP odražava obvezu ugovornih stranaka SZP-a za postizanje zajedničkog cilja daljnjeg uklanjanja prepreka pristupu tržištu kako bi se postigle što veće pogodnosti za potrošače, zračne prijevoznike, radnu snagu i zajednice s obje strane Atlantika.
Regulation (EU) 2019/4 of the European Parliament and of the Council
Uredba (EU) 2019/4 Europskog parlamenta i Vijeća
on the manufacture, placing on the market and use of medicated feed, amending Regulation (EC) No 183/2005 of the European Parliament and of the Council and repealing Council Directive 90/167/EEC
o proizvodnji, stavljanju na tržište i uporabi ljekovite hrane za životinje, o izmjeni Uredbe (EZ) br. 183/2005 Europskog parlamenta i Vijeća i o stavljanju izvan snage Direktive Vijeća 90/167/EEZ
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 43(2) and point (b) of Article 168(4) thereof,
uzimajući u obzir Ugovor o funkcioniranju Europske unije, a posebno njegov članak 43. stavak 2. i članak 168. stavak 4. točku (b),
Council Directive 90/167/EEC constitutes the Union’s regulatory framework for the preparation, placing on the market and use of medicated feed.
Direktiva Vijeća 90/167/EEZ čini regulatorni okvir Unije za pripremu, stavljanje na tržište i uporabu ljekovite hrane za životinje.
The rules concerning medicated feed have a significant influence on the keeping and on the rearing of animals, including non-food-producing animals, and on the production of products of animal origin.
Pravila koja se odnose na ljekovitu hranu za životinje imaju znatan utjecaj na držanje i uzgoj životinja, uključujući životinje koje se ne koriste za proizvodnju hrane, kao i na proizvodnju proizvoda životinjskog podrijetla.
The pursuit of a high level of protection of human health is one of the fundamental objectives of Union food law, as laid down in Regulation (EC) No 178/2002 of the European Parliament and of the Council, and the general principles laid down in that Regulation should apply to the placing on the market and use of feed without prejudice to more specific Union legislation.
Ostvarivanje visokog stupnja zaštite zdravlja ljudi jedan je od temeljnih ciljeva propisa Unije o hrani, kako je utvrđeno u Uredbi (EZ) br. 178/2002 Europskog parlamenta i Vijeća, i opća načela utvrđena u toj uredbi trebala bi se primjenjivati na stavljanje na tržište i uporabu hrane za životinje ne dovodeći u pitanje konkretnije zakonodavstvo Unije.
In addition, the protection of animal health constitutes one of the general objectives of Union food law.
Osim toga, zaštita zdravlja životinja jedan je od općih ciljeva propisa Unije o hrani.
Prevention of disease is better than cure.
Sprečavanje bolesti bolje je od liječenja.
Medicinal treatments, especially with antimicrobials, should never replace good husbandry, bio-security and management practices.
Liječenje, posebno antimikrobicima, nikad ne bi trebalo zamijeniti dobre prakse uzgoja, biološke sigurnosti i upravljanja.
Experience with the application of Directive 90/167/EEC has shown that further measures should be taken to strengthen the effective functioning of the internal market and to explicitly give and improve the possibility to treat non-food-producing animals with medicated feed.
Iskustvo s primjenom Direktive 90/167/EEZ pokazalo je kako bi trebalo poduzeti daljnje mjere za jačanje učinkovitog funkcioniranja unutarnjeg tržišta te za izričito pružanje i poboljšanje mogućnosti liječenja životinja koje se ne koriste za proizvodnju hrane ljekovitom hranom za životinje.
Medicated feed is one of the routes for the oral administration of veterinary medicinal products.
Ljekovita hrana za životinje jedan je od načina oralne primjene veterinarsko-medicinskih proizvoda.
Medicated feed is a homogeneous mixture of feed and veterinary medicinal products.
Ljekovita hrana za životinje homogena je mješavina hrane za životinje i veterinarsko-medicinskih proizvoda.
Other routes for oral administration, such as mixing of water for drinking with a veterinary medicinal product or manual mixing of a veterinary medicinal product into feed should not fall within the scope of this Regulation.
Ostali načini oralne primjene, kao što su miješanje vode za piće s veterinarsko-medicinskim proizvodom ili ručno miješanje veterinarsko-medicinskog proizvoda u hranu za životinje, ne bi trebali biti obuhvaćeni područjem primjene ove Uredbe.
The authorisation for use in feed, the manufacture, distribution, advertising and supervision of those veterinary medicinal products are governed by Regulation (EU) 2019/6 of the European Parliament and of the Council.
Odobrenje za uporabu u hrani za životinje, proizvodnja, distribucija, oglašavanje i nadzor tih veterinarsko-medicinskih proizvoda uređeno je Uredbom (EU) 2019/6 Europskog parlamenta i Vijeća.
Regulation (EU) 2019/6 applies to veterinary medicinal products, including those products which Directive 90/167/EEC referred to as ‘pre-mixes’, until such time as those products are included in medicated feed or intermediate products, after which this Regulation applies to the exclusion of Regulation (EU) 2019/6.
Uredba (EU) 2019/6 primjenjuje se na veterinarsko-medicinske proizvode, uključujući proizvode koje se u Direktivi 90/167/EEZ naziva „premiksi”, sve dok se ti proizvodi ne uključuju u ljekovitu hranu za životinje ili međuproizvode, nakon čega se umjesto Uredbe (EU) 2019/6 primjenjuje ova Uredba.
As a type of feed, medicated feed and intermediate products fall within the scope of Regulations (EC) No 183/2005, (EC) No 767/2009, (EC) No 1831/2003 and Directive 2002/32/EC of the European Parliament and of the Council.
Kao vrsta hrane za životinje, ljekovita hrana za životinje i međuproizvodi obuhvaćeni su područjem primjene uredaba (EZ) br. 183/2005, (EZ) br. 767/2009, (EZ) br. 1831/2003 i Direktive 2002/32/EZ Europskog parlamenta i Vijeća.
Thus, whenever medicated feed is manufactured with a compound feed all relevant Union legislation on compound feed applies and whenever medicated feed is manufactured from a feed material, all relevant Union legislation on feed material applies.
Stoga, kad god se ljekovita hrana za životinje proizvodi od krmne smjese, primjenjuje se cjelokupno relevantno zakonodavstvo Unije o krmnim smjesama te kad god se ljekovita hrana za životinje proizvodi od krmiva, primjenjuje se cjelokupno relevantno zakonodavstvo Unije o krmivu.
This applies to feed business operators, whether they operate in a feed mill, with a specially equipped vehicle or on-farm, as well as to feed business operators storing, transporting or placing on the market medicated feed and intermediate products.
To se primjenjuje na subjekte u poslovanju s hranom za životinje, neovisno o tome posluju li u tvornici hrane za životinje, s posebno opremljenim vozilom ili na poljoprivrednim gospodarstvima, kao i na subjekte u poslovanju s hranom za životinje koji skladište, prevoze ili stavljaju na tržište ljekovitu hranu za životinje i međuproizvode.
Specific provisions for medicated feed and intermediate products should be established concerning facilities and equipment, personnel, manufacture, quality control, storage, transport, record-keeping, complaints, product recalls and labelling.
Trebalo bi utvrditi posebne odredbe za ljekovitu hranu za životinje i međuproizvode u pogledu objekata i opreme, osoblja, proizvodnje, kontrole kvalitete, skladištenja, prijevoza, vođenja evidencije, pritužbi, opoziva proizvoda i označivanja.
Medicated feed imported into the Union must satisfy the general obligations laid down in Article 11 of Regulation (EC) No 178/2002 and the import conditions laid down in Regulation (EC) No 183/2005 and in Regulation (EU) 2017/625 of the European Parliament and of the Council.
Ljekovita hrana za životinje koja se uvozi u Uniju mora zadovoljavati opće obveze utvrđene u članku 11. Uredbe (EZ) br. 178/2002 te uvjete uvoza utvrđene u Uredbi (EZ) br. 183/2005 i Uredbi (EU) 2017/625 Europskog parlamenta i Vijeća.
Within that framework, medicated feed imported into the Union should be considered as falling within the scope of this Regulation.
Unutar tog okvira trebalo bi smatrati da je ljekovita hrana za životinje koja se uvozi u Uniju obuhvaćena područjem primjene ove Uredbe.
Without prejudice to the general obligations laid down in Article 12 of Regulation (EC) No 178/2002 concerning exports of feed to third countries, this Regulation should apply to medicated feed and intermediate products which are manufactured, stored, transported or placed on the market within the Union with the intention to be exported.
Ne dovodeći u pitanje opće obveze utvrđene u članku 12. Uredbe (EZ) br. 178/2002 u vezi s izvozom hrane za životinje u treće zemlje, ova Uredba trebala bi se primjenjivati na ljekovitu hranu za životinje i međuproizvode koji se proizvode, skladište, prevoze ili stavljaju na tržište unutar Unije radi izvoza.
However, the specific requirements concerning labelling, prescription and use of medicated feed and intermediate products, laid down in this Regulation, should not apply to products intended to be exported.
Međutim, posebni zahtjevi u vezi s označivanjem, izdavanjem recepata i uporabom ljekovite hrane za životinje i međuproizvoda utvrđeni u ovoj Uredbi ne bi se trebali primjenjivati na proizvode namijenjene za izvoz.
While veterinary medicinal products and the supply thereof are covered by Regulation (EU) 2019/6, intermediate products are not and should therefore be specifically covered by this Regulation in a corresponding way.
Veterinarsko-medicinski proizvodi i opskrba njima obuhvaćeni su Uredbom (EU) 2019/6, no međuproizvodi nisu te bi stoga trebali biti na odgovarajući način posebno obuhvaćeni ovom Uredbom.
Medicated feed should be manufactured only with veterinary medicinal products authorised for the purpose of the manufacture of medicated feed and the compatibility of all compounds used should be ensured for the purpose of safety and efficacy of the product.
Ljekovita hrana za životinje trebala bi se proizvoditi samo s veterinarsko-medicinskim proizvodima odobrenima u svrhu proizvodnje ljekovite hrane za životinje te bi trebalo osigurati kompatibilnost svih upotrijebljenih sastojaka kako bi proizvod bio siguran i djelotvoran.
Additional specific requirements or instructions for the inclusion of the veterinary medicinal products into feed should be provided for to ensure safe and efficient treatment of the animals.
Trebalo bi predvidjeti dodatne posebne zahtjeve ili upute za dodavanje veterinarsko-medicinskih proizvoda u hranu kako bi se zajamčilo neškodljivo i djelotvorno liječenje životinja.
Homogeneous dispersion of the veterinary medicinal product into the feed is also crucial for the manufacture of a safe and efficient medicated feed.
Homogena raspršenost veterinarsko-medicinskog proizvoda u hrani za životinje također je iznimno važna za proizvodnju sigurne i učinkovite ljekovite hrane za životinje.
Therefore, the possibility to establish criteria, such as target values, for the homogeneity of the medicated feed should be provided for.
Stoga bi trebalo predvidjeti mogućnost uspostavljanja kriterija, kao što su ciljne vrijednosti, za homogenost ljekovite hrane za životinje.
Feed business operators may manufacture within one establishment a broad range of feeds for different target animals and containing different types of compounds such as feed additives or veterinary medicinal products.
Subjekti u poslovanju s hranom za životinje mogu unutar jednog objekta proizvoditi široku paletu hrane za životinje koja je namijenjena različitim životinjama i sadržava različite vrste smjesa poput dodataka hrani za životinje ili veterinarsko-medicinskih proizvoda.
The manufacture of different types of feed after each other in the same production line may result in the presence of traces of an active substance in the line, which ends up in the beginning of the production of another feed.
Pri proizvodnji različitih vrsta hrane za životinje jedne za drugom na istoj proizvodnoj liniji mogu na liniji ostati tragovi djelatne tvari, koji se zatim pojavljuju u prvim proizvodima druge vrste hrane za životinje.